These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20346223)

  • 1. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
    Xia Y; Liu YL; Yang KH; Chen W
    Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
    J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
    Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
    Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
    Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
    Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
    Fu L; Zhang J; Li L; Yang Y; Yuan Y
    Oncol Lett; 2020 Feb; 19(2):1165-1174. PubMed ID: 31966046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of survivin/glyceraldehyde-3-phosphate dehydrogenase ratio in urine exfoliated cells for the detection of bladder tumor].
    Sakamoto Y; Nishioka J; Noma K; Yasuda K; Nakatani K; Kise H; Sugimura Y; Nobori T
    Rinsho Byori; 2011 May; 59(5):446-51. PubMed ID: 21706857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.
    Ku JH; Godoy G; Amiel GE; Lerner SP
    BJU Int; 2012 Sep; 110(5):630-6. PubMed ID: 22353238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.
    Kenney DM; Geschwindt RD; Kary MR; Linic JM; Sardesai NY; Li ZQ
    Tumour Biol; 2007; 28(2):57-62. PubMed ID: 17259754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine detection of survivin and diagnosis of bladder cancer.
    Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
    JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].
    Jiang LL; Xie MM; Wang XR; Zhao Y; Wang ZJ
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3520-2. PubMed ID: 24521893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of urinary survivin as a diagnostic marker in bladder cancer.
    Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
    Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis.
    Zhou Z; Zou L; Guan Y; Jiang L; Liu Y; Zhang X; Huang X; Ren H; Li Z; Niu H; Liao H; Zhang X; Pan H; Rong S; Ma H
    Urol Oncol; 2024 May; 42(5):133-143. PubMed ID: 38418270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
    Sun J; Hou JQ; He J; He XF; Wen DG
    Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas.
    Pina-Cabral L; Santos L; Mesquita B; Amaro T; Magalhães S; Criado B
    Clin Transl Oncol; 2007 Nov; 9(11):731-6. PubMed ID: 18055328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
    Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
    World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and significance of survivin mRNA in urinary bladder carcinomas.
    Wang H; Xi X; Kong X; Huang G; Ge G
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
    Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.
    Pu XY; Wang ZP; Chen YR; Wang XH; Wu YL; Wang HP
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):659-65. PubMed ID: 18026991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.